Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Positioning Imatinib for Pulmonary Arterial Hypertension
NCT04416750Phase 2Unknown
- Sponsor
- Imperial College London
- Start
- Jan 2021
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in pulmonary arterial hypertension (PAH), sponsored by Imperial College London. Status: unknown.
02
Drugs
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT04416750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04416750.